trending Market Intelligence /marketintelligence/en/news-insights/trending/qtuR3atUHSJtUc6UFgd9pg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Roche collaborates with Warp Drive to discover antibiotics

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Roche collaborates with Warp Drive to discover antibiotics

Roche Holding AG is collaborating with Warp Drive Bio Inc. to discover and develop multiple antibiotics.

Under the collaboration, Warp Drive will deploy its proprietary Genome Mining Platform to advance multiple classes of antibiotics with activity against clinically important, drug-resistant, Gram-negative pathogens.

Roche will receive an option to acquire global license to develop and commercialize certain antibiotics developed under the collaboration.

Warp Drive will receive $87 million in up-front payment and will be eligible to receive up to $300 million in specific clinical, regulatory and sales milestones on products licensed to Roche. Warp Drive will also be eligible for royalties on future net sales.

Warp Drive is identifying and evaluating over 100 classes of potential antibiotics that were previously undiscovered and thus never analyzed for their impact on human health.